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Significance of the Tks4 scaffold 
protein in bone tissue homeostasis
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Bálint Szeder1, Diána Mező1, Dóra Kállai1, Kitti Koprivanacz1, Balázs L. Merő1, Metta Dülk1, 
József Tóvári4, Péter Vajdovich5, Ş. Neslihan Şenel6, Ilknur Özcan6, Zsuzsanna Helyes7, 
Csaba Dobó-Nagy3 & László Buday1,8
The main driver of osteoporosis is an imbalance between bone resorption and formation. The 
pathogenesis of osteoporosis has also been connected to genetic alterations in key osteogenic factors 
and dysfunction of bone marrow mesenchymal stem/stromal cells (BM-MSCs). Tks4 (encoded by the 
Sh3pxd2b gene) is a scaffold protein involved in podosome organization. Homozygous mutational 
inactivation of Sh3pxd2b causes Frank-ter Haar syndrome (FTHS), a genetic disease that affects bone 
tissue as well as eye, ear, and heart functions. To date, the role of Tks4 in adult bone homeostasis has 
not been investigated. Therefore, the aim of this study was to analyze the facial and femoral bone 
phenotypes of Sh3pxd2b knock-out (KO) mice using micro-CT methods. In addition to the analysis of the 
Sh3pxd2b-KO mice, the bone microstructure of an FTHS patient was also examined. Macro-examination 
of skulls from Tks4-deficient mice revealed craniofacial malformations that were very similar to 
symptoms of the FTHS patient. The femurs of the Sh3pxd2b-KO mice had alterations in the trabecular 
system and showed signs of osteoporosis, and, similarly, the FTHS patient also showed increased 
trabecular separation/porosity. The expression levels of the Runx2 and osteocalcin bone formation 
markers were reduced in the bone and bone marrow of the Sh3pxd2b-KO femurs, respectively. Our 
recent study demonstrated that Sh3pxd2b-KO BM-MSCs have a reduced ability to differentiate into 
osteoblast lineage cells; therefore, we concluded that the Tks4 scaffold protein is important for 
osteoblast formation, and that it likely plays a role in bone cell homeostasis.
Osteoporosis is a globally distributed, multifactorial metabolic bone disease characterized by dysregulation of 
bone tissue remodeling. Bone homeostasis is maintained via a fine balance between bone formation and bone 
resorption. Although the mechanisms of these osteoporotic processes have been extensively studied, the genetic 
factors1,2 and molecules that influence bone homeostasis are still under investigation3–6.
Scaffold proteins modulate cellular signaling by bringing regulatory proteins, enzymes or actin-organizing 
structures into close proximity7. The Tks protein family consists of large, multidomain scaffold proteins that 
are phosphorylated by the Src kinase, hence the acronym tyrosine kinase substrate (Tks)8. Tks4 contains four 
Src Homology 3 (SH3) domains, one Phox Homology domain (PXD) and several conserved linear motifs, e.g., 
proline-rich regions9. The Tks4-encoding gene was named Sh3pxd2b based on this domain structure. The pri-
mary function of the PX domain is to directly bind to membrane-associated phosphoinositides to tether Tks4 to 
the cell membrane. The SH3 domains mediate protein-protein interactions and are docking sites for other signal-
ing components. Tks4 is involved in signal transduction in the EGFR pathway10. When Tks4 is phosphorylated by 
the EGFR-activated Src kinase, it interacts with cortactin to regulate the actin cytoskeleton. Tks4 is a key scaffold 
protein during podosome formation11; furthermore, it participates in reactive oxygen species (ROS) production 
by tumor cells12 and is necessary for mesenchymal stem/stromal cell (MSC) differentiation13.
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Homozygous loss-of-function mutations in Sh3pxd2b gene lead to deletion or dysfunction of Tks4 pro-
tein, and lack of functional Tks4 causes a rare hereditary disease called Frank-ter Haar syndrome (FTHS, 
OMIM:249420)14. FTHS patients exhibit several distinct symptoms, including shortened and bowing long bones, 
kyphosis, cardiac deficiencies caused by valve or septal defects, craniofacial and dental abnormalities, and glau-
coma15–20. Although some possible functions of Tks4 have been studied, the precise mechanisms through which 
Tks4 influences the FTHS-affected tissues remain elusive. To develop an animal model for studying FTHS, we 
generated a Tks4 knockout mouse strain with a targeted disruption of exons 5 and 6 in Sh3pxd2b13, and, as shown 
in our previous study, Tks4 was not detected in tissue from these Sh3pxd2b-KO mice13. Several phenotypes of the 
Sh3pxd2b-KO C57Bl/6 mice recapitulate FTHS pathologies, including craniomaxillofacial malformations, growth 
retardation (manifested by reduced long bone size and body mass), glaucoma and kyphosis13; furthermore, like 
FTHS patients, the Tks4-deficient mice develop heart failure. Although the abnormal bone morphology observed 
in the FTHS patients and the Sh3pxd2b-KO mice is a hallmark of the Tks4 mutant phenotype, the roles of Tks4 
in in situ bone structure maintenance and bone homeostasis have not been investigated. To explore these open 
questions, we analyzed the bone structures of a unique adult FTHS patient and our Tks4-deficient mice in detail.
The analyses of the skulls and femurs of the Sh3pxd2b-KO mice and the mandibular bone of the FTHS 
patient revealed that the bone microstructure is disturbed in the absence of Tks4. Furthermore, the Tks4-mutant 
mice exhibited an osteoporotic phenotype, suggesting that the Tks4 scaffold protein is involved in osteoporotic 
processes.
Results
Cephalometric analysis of the craniofacial malformation in Tks4-deficient mice. Micro-CT 
imaging was used to assess the craniofacial phenotypes of eight-month-old homozygous Tks4-deficient mice, 
and 3D reconstructions of the skulls were generated (Fig. 1a). The skulls of the Sh3pxd2b-KO mice exhibited 
significant reductions in length and width compared with the skulls of the wild type mice, and there was no dif-
ference in skull height. These observations indicate that loss of Tks4 leads to the formation of a domed cranium 
(Fig. 1b). Moreover, the skulls of the Sh3pxd2b-KO mice had a lower length:width:height ratio compared with 
that of the wild type mice, showing that the Tks4-deficient mice have a compressed skull shape (Fig. 1c). The most 
Figure 1. Cephalometric analysis of the cranial models of wild type and Sh3pxd2b-KO mice. (a) The 
dorsal, lateral and ventral views of representative 3D renderings of the skulls from 8-month-old wild type 
and Sh3pxd2b-KO mice show significant dysmorphology. (b) Sh3pxd2b-KO mice were compared to their 
genotypically wild type littermates to evaluate several parameters, including skull length, width, and height and 
mandible length. The anatomical landmark points used for the measurements are listed in the Methods section. 
Relative comparisons of the individual skull parameters: the skull length/width/height ratio (c), the skull length/
femur length ratio (d) and the mandible length/femur length ratio (e). The differences in the data were analyzed 
by Student’s t-test and three Sh3pxd2b-KO and three wild type mice were used. *p < 0.05. (f) Comparison of the 
dysmorphologies observed in skulls from Sh3pxd2b-KO mice with those reported in FTHS patients.
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obvious difference between the wild type and Sh3pxd2b-KO skulls was a foreshortening of the anterior-posterior 
length. Comparison of the relative skull length to femur length ratio and the mandibular length to femur length 
ratio showed that the relative values in the Sh3pxd2b-KO mice were smaller than those in the wild type animals 
(Fig. 1d,e). Based on these observations, we concluded that the Tks4-deficient mice are, like FTHS patients, 
brachycephalic. Furthermore, the linear and relative mandibular lengths were also reduced in the Sh3pxd2b-KO 
mice, indicating micrognathia (Fig. 1a,c). We also analyzed 3D reconstructions of skulls from 28-day-old mice, 
and we observed similar ossification of the cranial base in the Sh3pxd2b-KO and wild type mice. The cranial 
and facial sutures were still visible and were not fused at the time of the examination in the mice in both groups. 
However, we observed wider anterior fontanelles in the young Sh3pxd2b-KO mice compared with those of the 
wild type mice. The Sh3pxd2b-KO mice also showed dental abnormalities, such as pronounced crowding and 
open bite in the molar region. However, we also noted that there was no marked malocclusion in Sh3pxd2b-KO 
mice in the sagittal dimension, suggesting that the reduction in midfacial and mandibular growth is roughly pro-
portional. We performed systematic assessments of the cranioskeleton and searched for equivalent structures in 
the Sh3pxd2b-KO mice and the FTHS patient17. These analyses revealed several cranial malformations shared by 
the Tks4-deficient mice and the FTHS patient (Fig. 1f).
Tks4 deficiency results in altered bone micro-morphology. To determine the effects of loss of Tks4 
on bone architecture, micro-CT imaging was performed on the femurs of 4- and 8-month-old Sh3pxd2b-KO 
mice (Fig. 2). The bone to tissue volume ratio (BV/TV) is a basic parameter for characterizing bone microstruc-
ture complexity. The imaging results showed that the BV/TV ratios were consistently higher in the metaphysis 
regions of the control femurs compared to those in the corresponding regions in the Sh3pxd2b-KO mice at the 
two time points analyzed (Fig. 2a,b). These results indicate a more than 50% reduction in bone structure per 
given tissue volume in the Tks4-deficient mice relative to the wild type mice, a phenotype that can indicate shape 
changes in the bone trabecular system (Fig. 2a,b). Consistent with this observation, the trabeculae in the bones 
from 8-month-old Sh3pxd2b-KO mice were significantly thinner and fewer in number (Fig. 2b,c) compared with 
those in the 8-month-old wild type mice. In the bones of the 4-month-old Sh3pxd2b-KO mice, the thickness of 
the trabeculae was not significantly reduced; however, pronounced thickening developed over time (Fig. 2a). 
This observation reflects a tendency for the Sh3pxd2b-KO bones to develop a more disconnected trabecular 
structure during aging. Furthermore, we found that the trabecular pattern factor was about 50% higher in the 
metaphyseal region of the Tks4-deficient animals compared with that of the wild type animals, indicating that the 
Sh3pxd2b-KO trabeculae did not form the intricate net-like pattern seen in the controls (Fig. 2a,b). Our data also 
revealed an increase in the total porosity in the metaphyseal region of Sh3pxd2b-KO mice compared with that 
of the wild type mice. The cortical thickness of the femoral bones was also reduced in the Sh3pxd2b-KO mice at 
every time point analyzed compared with the corresponding values in the wild type animals (Fig. 2a,b,d). Based 
on the results of the bone microstructure analysis, which showed that reduced trabecular number was accompa-
nied by increased porosity, we concluded that Tks4 influences bone formation in vivo and that loss of this protein 
results in an osteoporotic bone phenotype.
We next asked whether the bone microstructural changes described above could also be observed in an FTHS 
patient or if they were specific to the Sh3pxd2b-KO mice. To address this question, the maxillofacial region of a 
male FTHS patient was analyzed using available cone beam CT (CBCT) data. The CBCT data were obtained at 
the ages of 21 and 24 prior to surgical treatment to remove impacted teeth and alleviate dental complaints. Köse et 
al. previously described the dental malformations of this FTHS patient, which included micrognathia, hypoplasia 
of the teeth, taurodont teeth and an open bite17. In this study, we reanalyzed the CBCT data focusing not on the 
dental problems, but rather on the features of the mandibular bone and bone micro-morphology. We used radi-
omorphometric parameters, including the panoramic mandibular index (PMI), to identify osteoporotic changes, 
as a reduction in the volume of the mandibular cortex, which is reflected in the PMI, is a manifestation of low 
bone density. We found that the PMI was significantly reduced in the FTHS patient compared to that of the con-
trol individuals (Fig. 3a). Furthermore, the cancellous bone was also analyzed, and several structural differences 
were observed compared to the healthy control individuals. The BV/TV ratio was significantly lower in the FTHS 
patient compared with that of the control individuals, whereas the trabecular separation and the total porosity of 
the mandibular bone were higher in the FTHS patient (Fig. 3b–d).
Taken together, the altered appearance of the bone trabecular network in the Sh3pxd2b-KO mice and the 
abnormal mandibular bone structure of the FTHS patient suggest that Tks4 plays a role in bone remodeling and 
homeostasis.
The potential involvement of osteoclast functions in the development of osteoporosis in 
Sh3pxd2b-KO mice. To further study the systemic effects of the observed osteoporotic phenotypes caused 
by the Tks4 mutation, we measured several biochemical serum parameters. The serum calcium and phosphate 
levels were within the normal ranges in the Sh3pxd2b-KO mice (similar to those of the wild type mice), indi-
cating that the calcium balance was not severely disturbed and that the trabecular bone loss did not affect the 
systemic calcium and phosphate levels (Fig. 4a,b). Since osteoporosis-related pathologies are caused by an imbal-
ance between the activities of osteoblasts and osteoclasts, the osteoporotic phenotype in the Sh3pxd2b-KO mice 
could be a consequence of impaired osteoclast or osteoblast functions. To address this possibility, we measured 
the serum levels of a bone formation marker, bone-specific alkaline phosphatase (BALP), and a bone resorption 
indicator, C-terminal telopeptide (CTX1)21. We did not detect a notable difference in the BALP serum levels 
(Fig. 4c). However, the CTX1 serum level was significantly lower in the Sh3pxd2b-KO mice compared with that 
of the wild type mice (Fig. 4d). To determine whether lack of Tks4 could affect the osteoclast population, we 
performed immunohistochemical analyses using osteoclast markers. Staining for cathepsin-K in distal femur sec-
tions showed no difference between the numbers of osteoclasts in the growth plate regions of the Sh3pxd2b-KO 
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and wild type mice (Fig. 4e). The Mmp9+ multinucleated osteoclast cell populations were quantified, and the 
results showed that the populations of mature osteoclasts were similar in size in bones from Sh3pxd2b-KO and 
wild type mice (Fig. 4f). Furthermore, the Mmp9 and TRAP expression levels (as measured by qPCR) were 
not significantly different in the bone tissue and bone marrow (BM) of the Sh3pxd2b-KO mice compared with 
their levels in the wild type mice (Fig. 4g,h). Although we showed that the CTX1 serum level was lower in the 
Sh3pxd2b-KO mice relative to that of the wild type mice, the osteoclast populations (based on the Mmp9, TRAP 
and cathepsin-K expression levels) were not significantly different between the Sh3pxd2b-KO and wild type mice. 
Thus, the osteoporotic phenotype of the Sh3pxd2b-KO mice was likely not due to increased osteoclast activity.
Tks4 regulates osteoblastogenesis. To measure Tks4 expression in adult bone, we first performed 
RT-PCR on bone and BM samples from wild type mice. Tks4 was expressed in both tissue types, although the 
relative Tks4 expression level was significantly higher in the BM fraction (Fig. 5a). Because we found higher Tks4 
expression in the immature cell-type-enriched BM fraction compared to that in the terminally-differentiated hard 
bone tissue, we propose that loss of Tks4 might have a more pronounced effect in precursor cells than in mature 
cell types (such as osteocytes). Furthermore, we previously demonstrated that Tks4 is expressed in BM mesenchy-
mal stem/stroma cells (BM-MSCs) and that MSCs derived from Sh3pxd2b-KO mice have a reduced capacity to 
differentiate into osteoblastic cells. Therefore, we measured the Tks4 expression level in osteogenic-differentiated 
wild type BM-MSCs to assess the presence of Tks4 during the osteoblast differentiation process. Western blotting 
was performed on cell lysates collected at six time points from in vitro osteogenic-differentiating BM-MSCs. 
Figure 2. Bone architecture measurements of Sh3pxd2b-KO mice. (a) Analysis of the trabecular 
microarchitecture in 4-month-old wild type and Sh3pxd2b-KO mice based on Micro-CT data. The data are 
shown as the mean ± SEM of three mice in each group. (b) Micro-CT-based analysis of parameters describing 
the trabecular microarchitecture at a later time point (8 months old) measured in six wild type and six 
Sh3pxd2b-KO mice. Student’s t-test was used to assess the statistical significance of the difference between the 
means of the two groups. *p < 0.05. (c) 3D images of the trabecular region of the femurs isolated from 8-month-
old wild type and Sh3pxd2b-KO mice. (d) Representative 2D images of the cortical bone at the femoral mid-
diaphysis from 8-month-old wild type and Sh3pxd2b-KO mice.
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The results showed that Tks4 protein was present at all of the tested time points during the BM-MSC differenti-
ation process (Fig. 5b), revealing that the Tks4 is expressed throughout the BM-MSC osteoblastic differentiation 
program.
To learn more about the status of the osteoblasts in the bone and BM of the Sh3pxd2b-KO mice, we measured 
the expression levels of osteoblast-related marker genes22,23. As shown in Fig. 5c, the expression of RunX2, an early 
marker of osteoblast differentiation, was significantly down-regulated in the Tks4-deficient bone tissue compared 
to its level in wild type bone tissue. Moreover, the expression level of osteocalcin, a widely used marker for mature 
osteoblasts, was significantly lower in BM from the Sh3pxd2b-KO mice compared with that in BM from wild 
type mice (Fig. 5d). These findings are consistent with the previously suggested role of Tks4 in BM-MSC differ-
entiation and support a model in which lack of Tks4 leads to an insufficient osteoblast supply. In addition to the 
normal osteoclast population in the bone of Sh3pxd2b-KO mice, we found that the potential of the BM-MSCs in 
the Sh3pxd2b-KO femurs to differentiate into the osteoblast lineage was impaired and that the expression levels of 
the osteoblast markers were reduced. One possible explanation for these phenotypes is that the cellular imbalance 
at the expense of bone-forming cells could lead to an osteoporotic phenotype of the Sh3pxd2b-KO mice.
Discussion
Previous studies suggested that the Tks4 scaffold protein plays a role in bone biology. For example, mesenchy-
mal stem cells with enhanced osteoblast differentiation potential have elevated Tks4 expression13. Furthermore, 
FTHS patients carrying mutations in Sh3pxd2b have skeletal dysplasia and craniofacial-bone dysmorphology24. 
A recent genome-wide mapping analysis of more than 700 outbred mice demonstrated that the gene encoding 
Tks4 (Sh3pxd2b) is a skull shape-determining quantitative trait locus (QTL), indicating that Tks4 is necessary 
for proper craniofacial bone shape development25. To elucidate the role of Tks4 in bone tissue formation and to 
investigate its functions in bone biology, we studied Sh3pxd2b-KO C57Bl/6 mice.
First, we compared detailed three-dimensional skull reconstructions reconstructed from micro-CT scans of 
wild type and Sh3pxd2b-KO mice. We found that the Sh3pxd2b-KO mice had domed craniums, brachycephalia, 
micrognathia, and wide fontanelle, features that are reminiscent of FTHS symptoms. There was a direct link 
between the skull morphologic alterations and the mutant genetic background in the Tks4-deficient mice, estab-
lishing this knock-out mouse strain as a valuable model system for studying craniofacial bone formation and 
maintenance.
Some mutations cause clinical symptoms related to craniofacial growth and result in abnormal osteogenesis 
in the long bones26,27. Although craniofacial dysmorphology is documented in Tks4-deficient FTHS patients, 
their skeletal bone phenotypes have not been examined in detail. Furthermore, an analysis of their bone micro-
structure is also lacking. The main aim of the current study was to examine the influence of Tks4 on skeletal 
phenotypes using micro-CT imaging. We show, for the first time, that loss of Tks4 leads to decreases in trabecular 
number and thickness that result in more porous bone tissue and osteoporotic bone trabecular structures in the 
femurs. Existing CBCT data from an FTHS patient were re-evaluated in this study, and the observations were 
consistent with the bone structure abnormalities in the Sh3pxd2b-KO mice. FTHS patients die during infancy or 
early childhood because of infections or heart failure. Consequently, it is difficult to obtain samples and examine 
the bone structure of adult FTHS patients, and it is impossible to conduct a large-scale examination of an FTHS 
cohort. Currently, only one adult FTHS patient has been documented17. CBCT was performed on his mandible at 
two time points due to dental problems. Reanalyzation of his CBCT data from a bone-structural perspective (i.e., 
cortical and cancellous bone) revealed abnormalities in the PMI and BV/TV and in the trabecular separation and 
total porosity parameters, which, taken together, indicate osteoporotic alterations. These results confirm that the 
bone abnormalities observed in the Sh3pxd2b-KO mice are highly reminiscent of the bone phenotypes of an adult 
FTHS patient, especially the alterations of the trabecular system.
Figure 3. CBCT-derived parameters describing the bone architecture of the FTHS patient. (a) Panoramic 
mandibular index (PMI), (20 analyzed VOIs from 10 control individuals are included in the plot); (4 analyzed 
VOIs from one FTHS patient measured at two time points are included in the plot). (b) BV/TV (c) trabecular 
separation and (d) total porosity are presented using box-and-whisker plots (40 analyzed VOIs from 10 control 
individuals are included in the plot); (10 analyzed VOIs from one FTHS patient measured at two time points are 
included in the plot). Student’s t-test was used to determine the statistical significance of the differences between 
the means of the parameters. *p < 0.05.
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The mechanisms by which Tks4 influences bone tissue remodeling remain obscure. We first examined the bone 
resorption component by measuring the levels of osteoclast-related markers in bone samples from Sh3pxd2b-KO 
mice. We did not detect any significant changes in the numbers of cathepsin-K- or Mmp9-stained osteoclasts. The 
expression levels of two osteoclast-related factors (TRAP, Mmp9) in the femurs of Sh3pxd2b-KO mice were also 
unaffected. Therefore, we concluded that the osteoporotic phenotype observed in the Tks4-deficient mice could 
not be caused by an expanded bone resorbing osteoclast cell population. Next, we measured the Tks4 expression 
levels in femurs and found higher Tks4 levels in the BM fraction compared with that of the hard bone tissue. This 
finding is particularly interesting given that Tks4 is required for the differentiation of BM-MSCs. In our previ-
ous study, we showed that BM-MSCs isolated from Sh3pxd2b-KO mice have impaired osteogenic differentiation 
capacity13. We also demonstrated that Sh3pxd2b-KO BM-MSCs had lower levels of the RunX2 and Osterix master 
transcription factors and reduced deposition of calcium-containing minerals during in vitro osteogenic differ-
entiation compared to these parameters in wild type cells. Moreover, our current results confirmed that Tks4 is 
present during in vitro differentiation of BM-MSCs into preosteoblasts and osteoblasts, reinforcing the notion 
that Tks4 influences osteoblast cell differentiation. We also showed that the expression levels of the early osteo-
blast differentiation marker RunX2 and the late osteoblast-related marker osteocalcin were significantly reduced 
in the hard bone and BM of Sh3pxd2b-KO mice, respectively. Therefore, Tks4 may be connected to bone cell 
biology by functioning in BM-MSCs during osteoblast differentiation, perhaps regulating proper bone formation, 
rather than affecting bone resorption. This conclusion is consistent with the findings of previous studies linking 
osteoporosis to MSC differentiation defects5,6,28–30.
Figure 4. Examination of osteoclast markers. Measurements of the serum levels of calcium (a), phosphate (b), 
bone-specific alkaline-phosphatase (BALP) (c) and C-terminal telopeptide (CTX1) (d). The data were analyzed 
using Student’s t-test and 5–6 mice were used per genotype. The data are expressed as the mean ± SEM. (e) 
cathepsin-K-positive and (f) Mmp9-positive multinucleated osteoclast cells were quantified using IHC in the 
metaphyseal region of femurs from wild type and Sh3pxd2b-KO mice. Representative images of the stainings 
are shown. The number of osteoclasts/field in three wild type and three Sh3pxd2b-KO mice were analyzed, 
and the data are reported as the mean ± SEM. The scale bar represents 50 μm. The osteoclast marker RT-PCR 
measurements were performed separately in femur BM (g) and hard bone tissue (h). The expression levels of the 
TRAP and Mmp9 bone resorption markers were measured. Three 7-month-old mice were used per genotype. 
The data are presented as the mean ± SEM, and the differences were analyzed by Student’s t-test. *p < 0.05.
7Scientific RepoRts |          (2019) 9:5781  | https://doi.org/10.1038/s41598-019-42250-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
Based on the in vitro differentiation defect observed in the Sh3pxd2b-KO BM-MSCs and the changes in the 
in vivo expression levels of osteoblast-related transcription factors, we conclude that the differentiation of the 
MSC-derived osteoblastic cell lineage is disturbed in Tks4-deficient mice, leading to improper formation of the 
bone trabecular system.
Methods
Participants and cone beam CT (CBCT) measurements. We analyzed CBCT results of a male FTHS 
patient obtained when he was 21 and 24 years old. He was surgically treated to remove several impacted teeth 
and the CBCT data helped to follow his recovery. The description of the patient was previously published in a 
case report17. The bone microstructure analyses based on the CBCT data were performed by us and are published 
here for the first time. The control population consisted of 20- to 25-year-old healthy males. Informed consent 
was obtained from all participants before the CBCT examination. The subject exclusion criteria were evidence of 
osteoporosis, drug consumption, and anamnesis of any pathological disorder. We included CBCT data from ten 
participants in the control group. The measurements made in this study, including those involving human sub-
jects, were conducted with ethical approval of the Regional and Institutional Committee of Science and Research 
Ethics, Semmelweis University, Budapest, Hungary (Ethics ID:138/2016). All methods involving measurements 
of humans were performed in accordance with the relevant guidelines and regulations of the Declaration of 
Helsinki for human research.
The CBCT measurements of the FTHS patient were performed at two time points (21 and 24 years old) in 
the Oral and Maxillofacial Radiology Department, Faculty of Dentistry at Istanbul University. We reanalyzed the 
CBCT data to characterize the mandibular bone tissue architecture. All of the measurements were pooled and 
included in the dataset (presented in Fig. 3). To analyze the cancellous bone component, six volumes of interest 
(VOIs) were chosen in the region between the apices of the canine and the premolars and the mandibular base, 
and these VOIs were analyzed using CTAn software (Bruker, Kontich, Belgium). Altogether, 40 different VOIs 
from the control group and 10 different VOIs from the FTHS patient were analyzed to calculate the bone volume/
tissue volume ratio (BV/TV), the trabecular separation and the total porosity parameter statistics. The mandib-
ular cortex measurement was performed according to Ledgerton’s statement31. The mental index (MI) and the 
distance from the lower border of the mandible to the lower border of the mental foramen (h) were measured on 
the left and right sides of the mandible. The MI/h ratios were calculated and are presented as the panoramic man-
dibular index (PMI). Altogether, 20 different PMIs from the control group and 4 different PMIs from the FTHS 
patient were measured and are presented in this study.
Figure 5. Examination of osteoblast markers. (a) The Tks4 expression levels were quantified separately in 
femoral hard bone tissue and BM by RT-PCR. The fold-change differences in the Tks4 mRNA levels were 
measured in five wild type mice (WT1-WT5), and the fold-changes were calculated using the 2−ΔΔCt method. 
(b) BM-MSCs isolated from wild type mice were cultured and differentiated into the osteogenic lineage. Cell 
lysates were collected during the differentiation period on days 0, 2, 4, 7, 14, and 21, and the Tks4 protein levels 
were measured using western blotting. Tubulin was used as the loading control. The expression levels of the 
RunX2 and osteocalcin bone formation markers were measured by RT-PCR separately in BM (c) and hard bone 
tissue (d). Three 7-month-old mice were used per genotype. The data are presented as the mean ± SEM, and the 
differences were analyzed by Student’s t-test. *p < 0.05.
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Animals. The currently valid institutional and national guidelines for the care and use of animals were followed 
during this study. The animal procedures were conducted under the approval of the Pest County Government 
Office Directory of Food Chain Safety (Hungary) Ethics Committee (Approval number: PEI/001/2042-6/2014). 
The animals were maintained and handled in accordance with the Guidelines for Accommodation and Care 
of Animals (European Convention for the Protection of Vertebrate Animals Used for Experimental and Other 
Scientific Purposes). The Sh3pxd2b-KO mice (in the C57Bl/6 genetic background) were originally created by 
TaconicArtemis13. To generate these mice, the fifth and sixth coding exons of Sh3pxd2b gene were flanked by 
loxP sites. The floxed exons were then removed via Cre-mediated recombination in the germ line to inactivate 
Sh3pxd2b. Sh3pxd2b-KO mice are infertile; therefore, heterozygous animals were crossed to produce homozygous 
Tks4-deficient animals and wild type littermates for the experiments. The excision of the fifth and sixth exons was 
complete in all of the Sh3pxd2b-KO mice, and the genotype was confirmed in each generation using a previously 
described genomic PCR method13. Several tissue samples (skeletal muscle, heart muscle, brain, lung, spleen, 
adipose tissue) were tested by western blotting to confirm the absence of Tks4, and Tks4 was clearly absent in the 
Sh3pxd2b-KO mice13. Age-, strain- and sex-matched genotypically wild type and Sh3pxd2b-KO mice were used 
in all of the experiments.
Cephalometric and micro-morphometric analyses using micro-computed tomography imaging. 
To quantify the craniofacial dimensions, skulls were dissected and removed from the mice and fixed in 10% for-
maldehyde. Formaldehyde-fixed femurs/tibias and skulls of age-matched wild-type and Sh3pxd2b-KO mice were 
imaged using a SkyScan 1172 (Bruker, SkyScan, Kontich, Belgium) micro-CT system. The scans were performed 
using a 5.03 μm isometric voxel size resolution under conditions of 50 kV and with a 200 (μA) X-ray source, 
using a 0.5-mm aluminum filter and a rotation step of 0.5°. Three-dimensional images were reconstructed and 
analyzed using the NRecon and CT-Analyser software. The length, width and height of each skull were measured. 
Landmark points were set according to a publication from the Richtsmeier laboratory32. The following landmark 
points were used: the cranium length was set between the basion (the midsagittal point on the anterior margin 
of the foramen magnum) and the intradentale superior (the most anterior midline point on the alveolar border 
superior to the septum between the central incisors); the cranium width was set between the right side and 
left side joining of the squamosal body to the zygomatic process of the squamosal; the cranium height was set 
between the basion (the midsagittal point on the anterior margin of the foramen magnum) and the intersection of 
the interparietal bones with the squamous portion of the occipital bone at the midline; the mandibular length was 
set between the tip of the mandibular angle and the inferior point on the mandibular symphysis. To accurately 
establish the landmark points on the cranium, we performed the measurements at three different time points and 
used the mean measurements for the statistical analysis. For the quantitative micro-morphometric measurements 
of the distal metaphysis of the femurs, 400 horizontal sections were analyzed starting 50 sections above the distal 
growth plate, and the boundaries of the trabecular area were selected33. The density threshold for the bone tissue 
was set manually by an experienced investigator. We measured the following parameters within each volume of 
interest (VOI): bone volume/tissue volume (BV/TV), trabecular number (TbN), trabecular thickness (TbTh), 
trabecular pattern factor (TbPf), and total porosity (TPo)34. The cortical bone parameters were evaluated in 100 
slices toward the middle of the diaphysis, with the first slice taken 500 slices distal to the growth plate. A total of 
6–6 mice were analyzed for each genotype in the 8-month-old group, and 3–3 mice were analyzed for each gen-
otype in the 4-month-old group.
Immunohistochemical analysis. The femurs and tibias were left connected to avoid damaging the knee 
joints, and the bones were cleaned of the muscles and fixed in paraformaldehyde. The bones were decalcified 
until they were soft and flexible then processed in paraffin. The embedded bones were sectioned longitudinally 
at a thickness of 2 μm. Serial sections were cut and stained with hematoxylin and eosin (H&E) or subjected to 
immunohistochemistry. The samples were deparaffinized in xylene and then hydrated in a series of aqueous 
alcohol solutions with decreasing alcohol concentrations. The sections were treated with H2O2 to block endog-
enous peroxidase activity, and antigen retrieval was performed by heat mediation. The slides were incubated 
in protein-blocking solution (Sniper blocking solution; Biocare Medical, Pacheco, CA) followed by incubation 
overnight at 4 °C with primary antibodies: rabbit polyclonal anti-Mmp9 (ab38898) or anti-cathepsin-K (ab19027) 
(Abcam). The sections were then incubated in Mach 2 Rabbit HRP Polymer (Biocare Medical) as the secondary 
antibody, and the colorimetric detection was performed with AEC (3-amino-9-ethylcarbazole). The immunos-
tained sections were counterstained with hematoxylin. The negative control specimens from the experimental 
mice were bone sections treated in the same way but omitting the primary antibodies. No background staining 
was observed in any of the samples. The stained sections were digitally scanned with a Panoramic 250 Flash II 
high-resolution scanner (3DHISTECH Ltd., Budapest, Hungary). Osteoclasts were defined as multinucleated 
cells observed in bone lacunae in the metaphyseal region. The AEC-stained (Mmp9+ or cathepsin-K+) osteo-
clasts were quantified in four fields-of-view of a defined size per slide by annotating them using CaseViewer 2.1 
software (3DHISTECH Ltd., Budapest, Hungary).
Quantitative RT-PCR. Mice were euthanized and the femurs were removed. The muscle tissue was carefully 
cleaned from the isolated femurs, and the BM was flushed out with HBSS. The BM suspensions were centrifuged, 
and the BM cell pellets were kept at −80 °C until treatment with TRIzol™ Reagent (Life Technologies). The bones 
were snap-frozen and pulverized in liquid nitrogen and then homogenized in TRIzol™ Reagent. Total RNA was 
isolated separately from the bone and the BM samples using the Direct-zol® MiniPrep kit (Zymo Research) 
according to the manufacturer’s instructions. In-column DNase I treatment was used to prevent genomic DNA 
contamination. cDNA samples were reverse transcribed from 200 ng of RNA with the First Strand cDNA Synthesis 
kit for RT-PCR (Roche) using the provided random primers. The Pre-Developed GAPDH TaqMan® assay (Life 
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Technologies) was used as the endogenous control. The TaqMan primers and probes (Thermo Fisher Scientific) 
used in this study were as follows: runt-related transcription factor 2 (Runx2) Mm00501584_m1, tartrate-resistant 
acid phosphatase TRAP (Acp5) Mm00475698_m1, bone gamma-carboxyglutamic acid-containing protein oste-
ocalcin, (Bglap) Mm03413826_mH, matrix metalloproteinase 9 (Mmp9) Mm00442991_m1, glyceraldehyde- 
3-phosphate-dehydrogenase (Gapdh) Mm99999915_g1, Tks4 (Sh3pxd2b) Mm00616672_m1.
The RT-PCR analyses were carried out using a StepOne™ Real-Time PCR System (Life Technologies), and the 
mRNA fold-changes were calculated using the 2−ΔΔCt method.
Serum tests. Blood serum samples were collected from six-month-old wild type and Sh3pxd2b-KO mice in 
Microvette 500z-gel serum separator tubes (Sarstedt AG & Co., Nümbrecht, Germany). Following centrifugation, 
the clear serum was removed and stored at −80 °C. The serum concentrations of the bone biomarkers (calcium 
and phosphate) were analyzed using an Olympus AU480 (Beckman Coulter) chemistry system. The serum CTX1 
and BALP levels were measured using commercially available ELISA assays (CTX1/CEA665Mu, Cloud-Clone 
Corp., Houston, TX, USA and BALP/CSB-E11914m, Cusabio Biotech, Wuhan, China) according to the manu-
facturers’ instructions.
Osteogenic differentiation of BM-MSCs. Femurs and tibiae were removed from the mice and the BM 
cells were flushed out. The washed BM cell suspensions were seeded in culture flasks (BD Falcon, Bedford, MA) 
in DMEM F12 medium (Thermo Fisher Scientific, Bremen, Germany) supplemented with 10% FBS and 5% horse 
serum (Invitrogen). After two days, the non-adherent cells were removed, and the adherent cells were further 
propagated for characterization of the BM-MSC phenotypes (as previously described and demonstrated in13). 
Osteogenic differentiation was induced using DMEM supplemented with 10% FCS, 10 mM β-glycerophosphate 
(Sigma-Aldrich), 50 μg/ml ascorbic acid (Sigma) and 0.01 μM hydrocortisone (Sigma-Aldrich). The cultures were 
incubated for 21 days and the medium was changed every 3 days.
Western blot analysis. Differentiated BM-MSC cells were collected for western blotting during osteo-
genic differentiation on days 0, 2, 4, 7, 14, and 21. The cells were lysed and the lysates were clarified by cen-
trifugation. Equal volumes of the samples were subjected to SDS-PAGE, and the proteins were transferred to 
PVDF membranes. The membranes were blocked and incubated overnight with anti-Tks4 (polyclonal rabbit) or 
anti-alpha-tubulin (monoclonal mouse, Sigma-Aldrich, USA) primary antibodies. Polyclonal anti-Tks4 specific 
antibody was generated earlier11. After several washes, the membranes were incubated with HRP-conjugated sec-
ondary antibodies (GE Healthcare, Lottle Chalfont, Buckinghamshire, UK). The reactive antigens were visualized 
with ECL detection reagents (Amersham Life Science, Buckinghamshire, UK).
Statistical analysis. All of the results are presented as mean ± SEM. Differences between two experimental 
groups (e.g., wild type vs. Sh3pxd2b-KO) were compared using unpaired Student’s t-tests. Graphpad Prism ver-
sion 5.0 software was used for the statistical analyses, and differences were considered significantly different at 
p < 0.05.
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